G

Glenmark Pharmaceuticals Ltd
NSE:GLENMARK

Watchlist Manager
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Watchlist
Price: 1 515.45 INR 0.69% Market Closed
Market Cap: 427.6B INR

Intrinsic Value

The intrinsic value of one GLENMARK stock under the Base Case scenario is 1 009.74 INR. Compared to the current market price of 1 515.45 INR, Glenmark Pharmaceuticals Ltd is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLENMARK Intrinsic Value
1 009.74 INR
Overvaluation 33%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Glenmark Pharmaceuticals Ltd

GLENMARK
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GLENMARK cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
IN
Pharmaceuticals
Market Cap
427.6B INR
IPO
Dec 10, 1999
IN
Pharmaceuticals
Market Cap
427.6B INR
IPO
Dec 10, 1999
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GLENMARK?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Glenmark Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Glenmark Pharmaceuticals Ltd

Current Assets 90.3B
Cash & Short-Term Investments 20.4B
Receivables 28.6B
Other Current Assets 41.3B
Non-Current Assets 62B
Long-Term Investments 1.1B
PP&E 35.5B
Intangibles 13.5B
Other Non-Current Assets 11.9B
Efficiency

Free Cash Flow Analysis
Glenmark Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Glenmark Pharmaceuticals Ltd

Revenue
122.5B INR
Cost of Revenue
-42.1B INR
Gross Profit
80.4B INR
Operating Expenses
-70.9B INR
Operating Income
9.5B INR
Other Expenses
-18.2B INR
Net Income
-8.8B INR
Fundamental Scores

GLENMARK Profitability Score
Profitability Due Diligence

Glenmark Pharmaceuticals Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive Operating Income
37/100
Profitability
Score

Glenmark Pharmaceuticals Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

GLENMARK Solvency Score
Solvency Due Diligence

Glenmark Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
67/100
Solvency
Score

Glenmark Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd

Wall Street analysts forecast GLENMARK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLENMARK is 1 719.76 INR with a low forecast of 1 277.65 INR and a high forecast of 2 133.6 INR.

Lowest
Price Target
1 277.65 INR
16% Downside
Average
Price Target
1 719.76 INR
13% Upside
Highest
Price Target
2 133.6 INR
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GLENMARK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GLENMARK Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one GLENMARK stock?

The intrinsic value of one GLENMARK stock under the Base Case scenario is 1 009.74 INR.

Is GLENMARK stock undervalued or overvalued?

Compared to the current market price of 1 515.45 INR, Glenmark Pharmaceuticals Ltd is Overvalued by 33%.

Back to Top